Vadadustat

Jun 18, 2020

Akebia Therapeutics Announces New Chief Financial Officer

May 05, 2020

Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis

May 05, 2020

Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial Results

Mar 23, 2020

Akebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual Conference